摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-Ethoxy-oct-1-ene | 44999-10-2

中文名称
——
中文别名
——
英文名称
8-Ethoxy-oct-1-ene
英文别名
8-Ethoxyoct-1-ene
8-Ethoxy-oct-1-ene化学式
CAS
44999-10-2
化学式
C10H20O
mdl
——
分子量
156.268
InChiKey
KFIZJDSHVLJUMU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    11
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    Sodium; 8-ethoxy-2-trimethylsilanylmethyl-octanoate甲醇乙腈 为溶剂, 以87%的产率得到8-Ethoxy-oct-1-ene
    参考文献:
    名称:
    通过阳极氧化在 β 位具有三甲基甲硅烷基团的羧酸的新型末端烯烃合成
    摘要:
    在β-位具有三甲基甲硅烷基的羧酸的阳极氧化以合理的产率仅产生端烯烃。
    DOI:
    10.1246/cl.1980.1517
点击查看最新优质反应信息

文献信息

  • Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
    申请人:Schrader Thomas
    公开号:US20050239808A1
    公开(公告)日:2005-10-27
    The invention on hand refers to diseases associated with abnormal protein structures, including Alzheimer's disease, Creutzfeldt-Jakob's disease, BSE and other prion-associated diseases. It is the task of the invention on hand to provide new active agents preventing the formation of amyloid plaques and to dissolve existing plaques, such agents being convenient for therapy, diagnosis and prophylaxis of diseases that are associated with abnormal protein structures. This task is performed in terms of the current invention by heterocyclic or aromatic agents with a rigid structure and a donor-acceptor-donor pattern (DAD), the latter being formed by donors and acceptors of hydrogen bridge linkages which comply with the β-sheet structure of the peptide or protein and thus fit as binding partners. The heterocyclic or aromatic agents are available at least as dimers. They recognise peptides and proteins with a β-sheet structure, form stable complexes with them and inhibit their aggregation to β-amyloid plaques. Furthermore, the new active agents are able to dissolve β-amyloid plaques that already exist. Another task of the current invention is to provide methods for the synthesis of said heterocyclic or aromatic compounds.
    该发明涉及与异常蛋白结构相关的疾病,包括阿尔茨海默病、克雅氏病、疯牛病和其他与朊病毒相关的疾病。该发明的任务是提供新的活性剂,预防淀粉样斑块的形成并溶解现有的斑块,这些活性剂方便用于治疗、诊断和预防与异常蛋白结构相关的疾病。本发明通过具有刚性结构和给受体给体(DAD)模式的杂环或芳香族活性剂来执行此任务,后者由氢桥键的给体和受体组成,符合肽或蛋白的β-片层结构,因此适合作为结合伙伴。这些杂环或芳香族活性剂至少以二聚体的形式存在。它们能够识别具有β-片层结构的肽和蛋白质,与它们形成稳定的复合物并抑制它们聚集成β-淀粉样斑块。此外,这些新的活性剂能够溶解已经存在的β-淀粉样斑块。本发明的另一个任务是提供合成所述杂环或芳香族化合物的方法。
  • Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer and uses thereof
    申请人:Mitsui Chemicals, Inc.
    公开号:EP1734061B1
    公开(公告)日:2010-04-07
  • Invention Concerning Agricultural Active Substances
    申请人:Greiner Andreas
    公开号:US20080213590A1
    公开(公告)日:2008-09-04
    The invention relates to supports consisting of nanoscalar polymer fibres, polymer tubes or hollow fibres for the application and targeted and/or delayed release of ingredients, in particular, agricultural active ingredients. The invention also relates to a method and a device for the production of supports of this type in a charged or empty state. The method and device use electrospinning technology.
  • METHOD FOR SEPARATING POLYMER SYSTEMS AND PORE-FREE POLYMER FILMS USED IN SAID METHOD
    申请人:Greiner Andreas
    公开号:US20090032461A1
    公开(公告)日:2009-02-05
    The subject matter of the invention is an innovative method for the separation of polymer systems regarding their molecular weight, chemical structure, chain architecture, and colloidal additives. Such separations are currently accomplished by selective precipitation from solution, by a fractionated crystallization also from solution, and by means of gel chromatographic methods. The invention pertains to a separation of polymer systems by means of permeation through polymer films—semi-crystalline, cross-linked, amorphous—with thicknesses in a nanometer scale. The restriction to thicknesses in a nanometer scale is essential for a high throughput of polymers. Of particular significance is the selectivity towards colloidal additives with a structure that is not in chain form.
  • Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof
    申请人:Imuta Junichi
    公开号:US20090137757A1
    公开(公告)日:2009-05-28
    A polar group-containing olefin copolymer having excellent adhesion properties to metals or polar resins and excellent compatibility therewith, a process for preparing the copolymer, a thermoplastic resin composition containing the copolymer, and uses thereof. The polar group-containing olefin copolymer comprises a constituent unit derived from an □-olefin of 2 to 20 carbon atoms, and a constituent unit derived from a straight-chain, branched or cyclic polar group-containing monomer having at the end a polar group such as a hydroxyl group or an epoxy group and/or a constituent unit derived from a macromonomer having at the end a polymer segment obtained by anionic polymerization, ring-opening polymerization or polycondensation. The polar group-containing olefin copolymer can be prepared by polymerizing the α-olefin with the polar group-containing monomer and/or the macromonomer in the presence of a metallocene catalyst. The polar group-containing olefin copolymer and the thermoplastic resin composition containing the copolymer are used for films, sheets, modifiers, building/civil engineering materials, automobile exterior trim, electric/electronic parts, coating bases, compatibilizing agents, etc.
查看更多